- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02561143
Effectiveness of Nutritional Counselling and "Improved Atta" Supplementation in Cachexic Adult Indian Cancer Patients
To Evaluate the Effectiveness of Nutritional Counselling and "Improved Atta" Supplementation in Delaying Progression of Cachexia to Refractory Cachexia in Adult Cancer Patients in Indian Population
Investigators are evaluating the nutritional role of IAtta supplementation along with nutritional counselling in delaying the progression of cachexia to refractory cachexia in adult cancer Indian patients. Patients will receive IAtta (100 g) or whole wheat flour (100 g) for daily consumption for 6 months. Dietary and physical activity counseling will be imparted every fortnight to patients.
Nutritional, biochemical, quality of life and anthropometric estimations will be assessed at baseline, after 3 months and at 6 months of intervention for all patients.
Investigators hypothesize that intake of nutrient rich bread mix IAtta (along with dietary and physical activity counselling) for six months will improve the health status and quality of life in free-living patients suffering from cancer cachexia.
Study Overview
Status
Detailed Description
Patients will be randomly distributed into two groups i.e. control and intervention group. 75 patients will be allocated in intervention group and receive nutrient rich flour mix i.e. IAtta (100 g) along with dietary and physical activity counseling and 75 patients will be allocated in the control group who will receive whole wheat flour with dietary and physical activity counseling. Intervention group patients will collect 14 packets of 100 g of IAtta every fortnight during their clinician appointments while the control patients will collect 14 packets of 100 g of whole wheat flour at every clinician visit for 6 months.
Dietary counseling for 30 minutes will be imparted to all patients on each visit by the nutritionist. Depending on the physical status of the patients, low level of physical activity (walking and/or stairs), will be encouraged daily during counseling sessions.
Nutritional, biochemical, quality of life and anthropometric estimations would be assessed at baseline, after 3 months and at 6 months of intervention for all patients.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
New Delhi, India, 110029
- All India Institute of Medical Sciences
-
-
-
-
-
London, United Kingdom, W1W 6UW
- University of Westminster
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Female, age 18 years and above.
- Diagnosed with cancer.
- Weight loss >5% from pre-treatment weight or BMI<20kg/m2.
- Hemoglobin level <12 g/dl.
- Energy intake < 1500 kcal/d (to be assessed on consultation)
Exclusion Criteria:
- Incapable to provide written consent.
- Patient diagnosed with refractory cachexia.
- Life expectancy < 3 months.
- Unresponsive to anti-cancer therapy.
- Patient is a pregnant woman or a nursing mother.
- Suffering from secondary illnesses.
- Gastrointestinal tract defects which affect nutrient absorption.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention group
Patients in the intervention group will be given dietary supplement (Improved Atta: 100 g) daily along with nutritional counseling and physical activity counseling for six months.
|
Improved Atta is a multi macro- micronutrient bread mix.
Patients will be given 100 grams of Improved Atta (to make unleavened bread) everyday for consumption for six months.
Depending on the physical status of the patients, low level of physical activity (walking and/or stairs), will be encouraged daily during counseling sessions.
Dietary counseling for 30 minutes will be imparted to all patients on every hospital visits by the nutritionist.
Consumption of cereals, roots and tubers, vegetables, legumes, nuts, energy dense fruits, milk products (and eggs for non-vegetarians) will be encouraged in their daily diets.
|
Placebo Comparator: Control group
Patients in the control group will be given whole wheat flour (100 g) daily along with nutritional counseling and physical activity counseling for six months.
|
Depending on the physical status of the patients, low level of physical activity (walking and/or stairs), will be encouraged daily during counseling sessions.
Dietary counseling for 30 minutes will be imparted to all patients on every hospital visits by the nutritionist.
Consumption of cereals, roots and tubers, vegetables, legumes, nuts, energy dense fruits, milk products (and eggs for non-vegetarians) will be encouraged in their daily diets.
Whole wheat flour 100 grams (to make unleavened bread) will be given everyday for consumption for six months to the patients.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in body weight at 6 months
Time Frame: Baseline, 3 months & 6 months
|
Body weight in kilograms will be assessed using a Tanita segmental composition scale at baseline, mid-intervention (3 months) and at the end of intervention (6 months).
|
Baseline, 3 months & 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in mid upper arm circumference (MUAC) at 6 months
Time Frame: Baseline, 3 months & 6 months
|
MUAC in centimeters will be measured using a non-stretchable measuring tape at baseline, mid-intervention (3 months) and at the end of intervention (6 months).
|
Baseline, 3 months & 6 months
|
Change in body fat percentage (BF%) at 6 months
Time Frame: Baseline, 3 months & 6 months
|
Four site skin fold thickness (SFT) measurement (i.e. triceps, biceps, subscapular and suprailiac) by the help of scientific Harpenden Skinfold Caliper will be noted to the nearest 0.2mm reading, to calculate percentage body density. Body fat percentage will be calculated using body density value in Siri equation. SFT will be measured at baseline, mid-intervention (3 months) and end of intervention (6 months) to determine the BF%. |
Baseline, 3 months & 6 months
|
Indian Migrant study food frequency questionnaire (IMS-FFQ)
Time Frame: Baseline, 3 months & 6 months
|
IMS-FFQ will be used to assess patient's daily energy (kcal), protein (g) and fat (g) intake at baseline, mid-intervention and end of intervention (6 months). Food frequency questionnaire is an accurate method to record the frequency of consumption of individual foods and can help provide information on patients' eating patterns. IMS-FFQ (Indian Migrant Study- Food Frequency Questionnaire) consists of 184 commonly consumed food items and is validated among the rural and urban Indian population. |
Baseline, 3 months & 6 months
|
Two day 24 hour dietary recall
Time Frame: Baseline, 3 months & 6 months
|
Two day 24 hour dietary recall will be used to assess patient's daily energy (kcal), protein (g) and fat (g) intake at baseline, mid-intervention and end of intervention (6 months). 24 hour dietary recall is an accurate method to understand patients' eating patterns. |
Baseline, 3 months & 6 months
|
Patient generated subjective global assessment (PGSGA)
Time Frame: Baseline, 3 months & 6 months
|
PGSGA will be used to assess patient nutritional status (category: well nourished, malnourished & severely malnourished) at baseline, mid-intervention and end of intervention (6 months). PG-SGA is most effective and sensitive tool for assessing and evaluating cancer patients' nutritional status and validated on Indian cancer patients. |
Baseline, 3 months & 6 months
|
Indian Migrant Study Physical Activity Questionnaire (IMS-PAQ)
Time Frame: Baseline, 3 months & 6 months
|
IMS-PAQ will assess patients' physical activity throughout the day.
Investigators will asses physical activity at three time points during the study: baseline, at 3 months of intervention and at 6 months end of intervention.
IMS-PAQ is a validated questionnaire on both Indian rural and urban population.
Patients' will report every activity performed with the average amount of time spent for each activity in the questionnaire.
Thereafter, investigators will calculate the average calories spent by every patient in the whole day.
|
Baseline, 3 months & 6 months
|
Change in quality of life by EORTC-QLQ- C30 (Quality of life Questionnaire) at 6 months
Time Frame: Baseline, 3 months & 6 months
|
EORTC-QLQ- C30 (European Organization for Research &Treatment of cancer) questionnaire will be used to analyse patients' quality of life at baseline, mid- intervention and at the end of intervention period.
A score will be calculated for all the15 domains covered in the questionnaire of 30 questions.These domains will be analysed and compared for the outcome in the two groups.
|
Baseline, 3 months & 6 months
|
Change in haemoglobin levels at 6 months
Time Frame: Baseline, 3 months & 6 months
|
Haemoglobin levels (g/dl) will be monitored at baseline, at three months and at the end of intervention (6 months).
|
Baseline, 3 months & 6 months
|
Change in serum albumin levels
Time Frame: Baseline, 3 months & 6 months
|
Serum albumin (g%) levels will be monitored at baseline, at three months and at the end of intervention (6 months).
|
Baseline, 3 months & 6 months
|
Change in C-reactive protein levels at 6 months
Time Frame: Baseline & 6 months
|
C-reactive protein (mg/L) levels will be monitored at baseline and at the end of intervention (6 months).
|
Baseline & 6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Neha Kapoor, PhD, University of Westminster
- Study Director: Ihab Tewfik, PhD, University of Westminster
Publications and helpful links
General Publications
- Kapoor N, Naufahu J, Tewfik S, Bhatnagar S, Garg R, Tewfik I. A public health nutrition intervention to delay the progression of cachexia to refractory cachexia in indian female cancer patients. Int. J. Food, Nutrition and Public Health. 2014;7:1-11.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IEC/NP-339/08.10.2014
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterRecruitingCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
UNC Lineberger Comprehensive Cancer CenterHyundai Hope On WheelsRecruitingCancer | Pediatric Cancer | Survivorship | Cancer MetastaticUnited States
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)Active, not recruitingAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Breast Cancer | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage... and other conditionsUnited States
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Colon Cancer | Hepatobiliary CancerUnited States
-
Johns Hopkins UniversityNational Cancer Institute (NCI); National Institute on Minority Health and...Enrolling by invitationCancer | Advanced Cancer | End Stage Cancer | MalignancyUnited States
Clinical Trials on Improved Atta
-
University of WestminsterAll India Institute of Medical Sciences, New DelhiCompletedCancer | CachexiaIndia, United Kingdom
-
Boston CollegeWashington University School of Medicine; Sri Ramachandra UniversityActive, not recruitingChronic Obstructive Pulmonary Disease | Asthma
-
Massachusetts General HospitalAlliance for Clinical Trials in Oncology Cancer Control Program (CCP)CompletedCancerUnited States
-
Slagelse HospitalRegion Zealand; Steno Diabetes Center Sjaelland; Center for Clinical Research...Recruiting
-
International Centre for Diarrhoeal Disease Research...University of Chicago; National Institute of Environmental Health Sciences... and other collaboratorsRecruitingCardiovascular Diseases | Lung Diseases | Immune Dysfunction | Household Air PolutionBangladesh
-
London School of Hygiene and Tropical MedicineCompletedDiarrhea | CholeraCongo, The Democratic Republic of the
-
Massachusetts General HospitalCompleted
-
Johns Hopkins Bloomberg School of Public HealthBrown University; National Institutes of Health (NIH); Universidad Peruana Cayetano... and other collaboratorsCompletedRespiratory Conditions Due to Other External Agents | Poisoning by Carbon Monoxide From Domestic FuelsKenya, Nepal, Peru
-
Kiwon Lee MDJFK Medical CenterRecruitingStroke | Ischemic Stroke | Intracerebral HemorrhageUnited States